Jury Urged To Return Verdict Against Takeda In Actos Case
A Philadelphia jury was sent to deliberate Wednesday afternoon after being urged to find that Takeda Pharmaceuticals Inc. had willfully worked to obscure evidence linking the blockbuster diabetes drug Actos to...To view the full article, register now.
Already a subscriber? Click here to view full article